Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 455Pancreatic Neoplasms 361Stomach Neoplasms 246Carcinoma, Hepatocellular 231Carcinoma, Non-Small-Cell Lung 164Colonic Neoplasms 145Esophageal Neoplasms 133Neoplasms 115Neoplasm Metastasis 112Ovarian Neoplasms 110Rectal Neoplasms 105Liver Neoplasms 101Breast Neoplasms 99Lung Neoplasms 78Melanoma 76Squamous Cell Carcinoma of Head and Neck 70Gastrointestinal Neoplasms 58Endometrial Neoplasms 57Carcinoma, Renal Cell 54Uterine Cervical Neoplasms 52Cholangiocarcinoma 52Biliary Tract Neoplasms 51Triple Negative Breast Neoplasms 49Head and Neck Neoplasms 48Sarcoma 46Prostatic Neoplasms 45Esophageal Squamous Cell Carcinoma 39Urinary Bladder Neoplasms 34Small Cell Lung Carcinoma 31Carcinoma 29

Interventions

Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Cognitive Dysfunction × Gastrointestinal × Clear all
NCT05552729 2022-09-23

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Yangzhou University

Phase 1/2 Unknown
114 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡